Advertisement

Table of Contents

September 01, 1984; Volume 26,Issue 2

You have access
Relationships between phosphoinositide and calcium responses to muscarinic agonists in astrocytoma cells.
S B Masters, T K Harden and J H Brown

Molecular Pharmacology September 1984, 26 (2) 149-155;
You have access
Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
M McKinney, S Stenstrom and E Richelson

Molecular Pharmacology September 1984, 26 (2) 156-163;
You have access
[3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
G R Luthin and B B Wolfe

Molecular Pharmacology September 1984, 26 (2) 164-169;
You have access
The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
B Ringdahl, B Resul, F J Ehlert, D J Jenden and R Dahlbom

Molecular Pharmacology September 1984, 26 (2) 170-179;
You have access
Hormonal inhibition of adenylate cyclase. A crucial role for Mg2+.
J Bockaert, B Cantau and M Sebben-Perez

Molecular Pharmacology September 1984, 26 (2) 180-186;
You have access
Photoaffinity cross-linking of a radioiodinated probe, 125I-A55453, into alpha 1-adrenergic receptors.
K E Dickinson, L M Leeb-Lundberg, S L Heald, J E Wikberg, J F DeBernardis, M G Caron and R J Lefkowitz

Molecular Pharmacology September 1984, 26 (2) 187-195;
You have access
Alpha 1-adrenergic receptor structure.
J C Venter, P Horne, B Eddy, R Greguski and C M Fraser

Molecular Pharmacology September 1984, 26 (2) 196-205;
You have access
Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
T G Zaremba and P H Fishman

Molecular Pharmacology September 1984, 26 (2) 206-213;
You have access
The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland.
K A Wreggett and A De Léan

Molecular Pharmacology September 1984, 26 (2) 214-227;
You have access
Kinetic differences between type I and type II benzodiazepine receptors.
R R Trifiletti, M M Lo and S H Snyder

Molecular Pharmacology September 1984, 26 (2) 228-240;
You have access
Evidence for two molecular forms of solubilized vasopressin receptors in rat kidney membranes. Regulation by guanyl nucleotides.
G Guillon, D Butlen and R Rajerison

Molecular Pharmacology September 1984, 26 (2) 241-247;
You have access
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.
J C Beaujouan, Y Torrens, A Viger and J Glowinski

Molecular Pharmacology September 1984, 26 (2) 248-254;
You have access
Enkephalin biosynthesis in adrenal medulla. Modulation of proenkephalin mRNA content of cultured chromaffin cells by 8-bromo-adenosine 3',5'-monophosphate.
T T Quach, F Tang, H Kageyama, I Mocchetti, A Guidotti, J L Meek, E Costa and J P Schwartz

Molecular Pharmacology September 1984, 26 (2) 255-260;
You have access
Phorbol ester-induced protein secretion in rat parotid gland. Relationship to the role of inositol lipid breakdown and protein kinase C activation in stimulus-secretion coupling.
J W Putney, J S McKinney, D L Aub and B A Leslie

Molecular Pharmacology September 1984, 26 (2) 261-266;
You have access
Influence of a tumor-promoting phorbol ester on the electrical response of B-cells to glucose and glyburide.
C S Pace

Molecular Pharmacology September 1984, 26 (2) 267-271;
You have access
Factors influencing the covalent binding of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene to ribonucleic acids.
T H Zytkovicz and C D Liarakos

Molecular Pharmacology September 1984, 26 (2) 269-275;
You have access
Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro.
V C Jordan, M E Lieberman, E Cormier, R Koch, J R Bagley and P C Ruenitz

Molecular Pharmacology September 1984, 26 (2) 272-278;
You have access
Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure.
V C Jordan and M E Lieberman

Molecular Pharmacology September 1984, 26 (2) 279-285;
You have access
Effects of calmodulin antagonists on immune mouse lymphocytes.
G Wolberg and T P Zimmerman

Molecular Pharmacology September 1984, 26 (2) 286-292;
You have access
Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
S R Ikeda, R S Aronstam, J W Daly, Y Aracava and E X Albuquerque

Molecular Pharmacology September 1984, 26 (2) 293-303;
You have access
Interactions of bupivacaine with ionic channels of the nicotinic receptor. Analysis of single-channel currents.
Y Aracava, S R Ikeda, J W Daly, N Brookes and E X Albuquerque

Molecular Pharmacology September 1984, 26 (2) 304-313;
You have access
The influence of local anesthetics on molecular organization in phosphatidylethanolamine membranes.
E C Kelusky and I C Smith

Molecular Pharmacology September 1984, 26 (2) 314-321;
You have access
In vitro studies on the distribution of probucol among human plasma lipoproteins.
S Urien, P Riant, E Albengres, R Brioude and J P Tillement

Molecular Pharmacology September 1984, 26 (2) 322-327;
You have access
Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom.
L J Marnett, P H Siedlik, R C Ochs, W R Pagels, M Das, K V Honn, R H Warnock, B E Tainer and T E Eling

Molecular Pharmacology September 1984, 26 (2) 328-335;
You have access
Studies on porphyrin metabolism in the kidney. Effects of trace metals and glutathione on renal uroporphyrinogen decarboxylase.
J S Woods, D L Eaton and C B Lukens

Molecular Pharmacology September 1984, 26 (2) 336-341;
You have access
Reaction of mutagenic phenacetin metabolites with glutathione and DNA. Possible implications for toxicity.
G J Mulder, F F Kadlubar, J B Mays and J A Hinson

Molecular Pharmacology September 1984, 26 (2) 342-347;
You have access
Hydroperoxyflavin-mediated oxidations of organosulfur compounds. Model studies for the flavin monooxygenase.
D R Doerge and M D Corbett

Molecular Pharmacology September 1984, 26 (2) 348-352;
You have access
Carcinogen-binding proteins. High-affinity binding sites for benzo[a]pyrene in mouse liver distinct from the Ah receptor.
S Collins and M A Marletta

Molecular Pharmacology September 1984, 26 (2) 353-359;
You have access
Mechanism of HgCl2 cytotoxicity in cultured mammalian cells.
O Cantoni, N T Christie, A Swann, D B Drath and M Costa

Molecular Pharmacology September 1984, 26 (2) 360-368;
You have access
Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
T Yokota, K Konno, S Shigeta and E De Clercq

Molecular Pharmacology September 1984, 26 (2) 376-380;
You have access
1-beta-D-arabinosyl-5-azacytosine. Cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells.
R I Glazer and M C Knode

Molecular Pharmacology September 1984, 26 (2) 381-387;
You have access
Analytical DNA flow cytometric analysis of deoxyadenosine toxicity in cultured human leukemic lymphoblasts.
R M Fox, E H Tripp and I W Taylor

Molecular Pharmacology September 1984, 26 (2) 388-394;